Description
IGF::OT::IGF "TESTOSTERONE PLUS FINASTERIDE"
First action · last action
2015-07-31 · 2019-05-15
Transactions
8
First transaction's obligation
$20,960
Base + all options value (sum of deltas)
$62,420
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I))
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 8 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-07-31+$20,960= $20,960
- Mod P000012016-06-21-$8,460= $12,500
- Mod P000022016-07-29+$13,500= $26,000
- Mod P000032017-07-31-$12,500= $13,500
- Mod P000042017-07-31+$13,500= $27,000
- Mod P000052017-09-28-$1,000= $26,000
- Mod P000062018-07-31+$8,460= $34,460
- Mod P000072019-05-15+$6,000= $40,460
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-07-31 | +$20,960 | $20,960 | IGF::OT::IGF "TESTOSTERONE PLUS FINASTERIDE" |
| Mod P00001· FUNDING ONLY ACTION | 2016-06-21 | −$8,460 | $12,500 | IGF::OT::IGF "TESTOSTERONE PLUS FINASTERIDE" |
| Mod P00002· EXERCISE AN OPTION | 2016-07-29 | +$13,500 | $26,000 | IGF::OT::IGF "TESTOSTERONE PLUS FINASTERIDE" |
| Mod P00003· FUNDING ONLY ACTION | 2017-07-31 | −$12,500 | $13,500 | IGF::OT::IGF "TESTOSTERONE PLUS FINASTERIDE" |
| Mod P00004· EXERCISE AN OPTION | 2017-07-31 | +$13,500 | $27,000 | IGF::OT::IGF "TESTOSTERONE PLUS FINASTERIDE" |
| Mod P00005· FUNDING ONLY ACTION | 2017-09-28 | −$1,000 | $26,000 | IGF::OT::IGF "TESTOSTERONE PLUS FINASTERIDE" |
| Mod P00006· EXERCISE AN OPTION | 2018-07-31 | +$8,460 | $34,460 | IGF::OT::IGF "TESTOSTERONE PLUS FINASTERIDE" |
| Mod P00007· FUNDING ONLY ACTION | 2019-05-15 | +$6,000 | $40,460 | IGF::OT::IGF "TESTOSTERONE PLUS FINASTERIDE" |
Related awards · 8
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI EAESX5KNA198)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24819C0129 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · AN42 · R&D- MEDICAL: HEALTH SERVICES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT) | $55,600 | FY2019 |
| VA573PA1356 | 573-NF/SG VETERANS HEALTH SYSTEM · 6505 · DRUGS AND BIOLOGICALS | $4,250 | FY2011 |
| VA573P14417 | 573-NF/SG VETERANS HEALTH SYSTEM · 6515 · MED & SURGICAL INSTRUMENTS,EQ & SUP | $4,875 | FY2011 |
| V573P14417 | 573S-NF/SG SMALL PURCHASE · 6505 · DRUGS AND BIOLOGICALS | $4,875 | FY2011 |
| VA573PA1260 | 573-NF/SG VETERANS HEALTH SYSTEM · 6515 · MED & SURGICAL INSTRUMENTS,EQ & SUP | $4,250 | FY2011 |
| V573PA1200 | 573S-NF/SG SMALL PURCHASE · 6505 · DRUGS AND BIOLOGICALS | $4,625 | FY2011 |
Other recipients under AN42 from 248-NETWORK CONTRACT OFFICE 8 (36C248) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24821C0041 | TRUSTEES OF BOSTON UNIVERSITY | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $32,050 | FY2021 |
| VA24817J1912 | MINBURN TECHNOLOGY GROUP, LLC | 248-NETWORK CONTRACT OFFICE 8 (36C248) | $142,470 | FY2017 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24815C0125_3600_-NONE-_-NONE- · retrieved 2026-09-26.